Palbociclib and hormonal therapy may extend survival in advanced breast cancer patients

The drug palbociclib when combined with hormonal therapy extends the survival of patients with advanced breast cancer, according to research published in theNew England Journal of Medicine.The Guardian
Source: Society for Endocrinology - Category: Endocrinology Source Type: news